Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis-Reference-Cited by-同舟云学术

Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis

Published:2004 Issue:4 Volume:50 Page:1296-1304
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Del Papa Nicoletta,Colombo Gualtiero,Fracchiolla Nicola,Moronetti Lorenza Mazzeo,Ingegnoli Francesca,Maglione Wanda,Comina Denise P.,Vitali Claudio,Fantini Flavio,Cortelezzi Agostino

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference47 articles.

1. THE PATHOPHYSIOLOGY OF SCLERODERMA

2. Systemic sclerosis: current pathogenetic concepts and future prospects for targeted therapy

3. Pathogenesis of systemic sclerosis: A vascular hypothesis

4. Studies of the microvascular endothelium in uninvolved skin of patients with systemic sclerosis: direct evidence for a generalized microangiopathy

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What have we learned on pre, very early, and early systemic sclerosis microcirculatory pathophysiology? A scoping review;Autoimmunity Reviews;2024-05

2. Endothelial Dysfunction in Systemic Sclerosis;International Journal of Molecular Sciences;2023-09-21

3. Effect of vasodilator and immunosuppressive therapy on the endothelial dysfunction in patients with systemic sclerosis;Clinical and Experimental Medicine;2022-06-25

4. G6PD is a critical enabler of hypoxia-induced accumulation of macrophages and platelets in mice lungs and contributor to lung inflammation;Vascular Pharmacology;2022-06

5. Endothelial Progenitor Cells: Relevant Players in the Vasculopathy and Lung Fibrosis Associated with the Presence of Interstitial Lung Disease in Systemic Sclerosis Patients;Biomedicines;2021-07-20